1-5 of 5
G. Caleb Alexander
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pharmacologic Treatment of Type 2 Diabetes in the U.S., Sweden, and Israel

Beini Lyu, Yingying Sang, Elizabeth Selvin, Alex R. Chang, G. Caleb Alexander, Cheli Melzer Cohen, Josef Coresh, Varda Shalev, Gabriel Chodick, Avraham Karasik, Juan-Jesus Carrero, Edouard L. Fu, Yang Xu, Morgan E. Grams, Jung-Im Shin
Journal: Diabetes Care
Diabetes Care 2022;45(12):2926–2934
https://doi.org/10.2337/dc22-1253
Published: 25 October 2022
View article titled, Pharmacologic Treatment of Type 2 Diabetes in the U.S., Sweden, and Israel
Open the PDF for Pharmacologic Treatment of Type 2 Diabetes in the U.S., Sweden, and Israel in another window
Journal Articles

Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium–Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes

Anna R. Kahkoska, Trine Julie Abrahamsen, G. Caleb Alexander, Tellen D. Bennett, Christopher G. Chute, Melissa A. Haendel, Klara R. Klein, Hemalkumar Mehta, Joshua D. Miller, Richard A. Moffitt, Til Stürmer, Kajsa Kvist, John B. Buse, N3C Consortium, Tim Q. Duong
Journal: Diabetes Care
Diabetes Care 2021;44(7):1564–1572
https://doi.org/10.2337/dc21-0065
Published: 20 July 2021
View article titled, Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium–Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes
Open the PDF for Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium–Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes in another window
Journal Articles

Ambulatory Treatment of Type 2 Diabetes in the U.S., 1997–2012

Lydia W. Turner, David Nartey, Randall S. Stafford, Sonal Singh, G. Caleb Alexander
Journal: Diabetes Care
Diabetes Care 2014;37(4):985–992
https://doi.org/10.2337/dc13-2097
Published: 08 March 2014
View article titled, Ambulatory Treatment of Type 2 Diabetes in the U.S., 1997–2012
Open the PDF for Ambulatory Treatment of Type 2 Diabetes in the U.S., 1997–2012 in another window
Includes: Supplementary data
Journal Articles

Changes in Glitazone Use Among Office-Based Physicians in the U.S., 2003–2009

Andrew Cohen, BS, Atonu Rabbani, PHD, Nilay Shah, PHD, G. Caleb Alexander, MD, MS
Journal: Diabetes Care
Diabetes Care 2010;33(4):823–825
https://doi.org/10.2337/dc09-1834
Published: 26 January 2010
View article titled, Changes in Glitazone Use Among Office-Based Physicians in the U.S., 2003–2009
Open the PDF for Changes in Glitazone Use Among Office-Based Physicians in the U.S., 2003–2009 in another window
Includes: Supplementary data
Journal Articles

Lack of Effect of Guideline Changes on LDL Cholesterol Reporting and Control for Diabetes Visits in the U.S., 1995–2004

Y. Richard Wang, MD, PHD, G. Caleb Alexander, MD, MS, David O. Meltzer, MD, PHD
Journal: Diabetes Care
Diabetes Care 2005;28(12):2942–2944
https://doi.org/10.2337/diacare.28.12.2942
Published: 01 December 2005
View article titled, Lack of Effect of Guideline Changes on LDL Cholesterol Reporting and Control for Diabetes Visits in the U.S., 1995–2004
Open the PDF for Lack of Effect of Guideline Changes on LDL Cholesterol Reporting and Control for Diabetes Visits in the U.S., 1995–2004 in another window